Ontario-based licensed cannabis grower CannTrust was sanctioned by Health Canada for conducting unlicensed cultivation and providing inaccurate information to the federal regulator, the company revealed today.
CannTrust’s greenhouse facility in Pelham, Ontario received a “noncompliant” rating by Health Canada for operating five unlicensed rooms, and at least 12,500 kilograms (27,500 pounds) is being held back from the market.
For context, the company harvested 9,400 kilograms in the entirety of the last financial quarter.
A producer can be assigned a noncompliant rating based on the number and seriousness of violations found by Health Canada’s inspectors.
It is only the fourth rating of noncompliance Health Canada has handed out since March 2017 after conducting more than 257 inspections.
In fiscal year 2018, Agrima Botanicals received a noncompliant rating and Natural Med Company earned two such ratings. Warning letters were handed out in all three cases.
Health Canada went a step further this time, placing “a hold” on 5,200 kilograms of dried cannabis inventory that was harvested in the unsanctioned rooms, CannTrust said in a press release, until the regulator deems that the company is compliant.
Additionally, CannTrust said it instituted “a voluntary hold” on approximately 7,500 kilograms of dried cannabis equivalent at its Vaughan manufacturing facility that had been produced in the unlicensed areas.
The growing in the unlicensed rooms took place from last October to as recently as March 2019, during which time CannTrust said it had pending applications for the rooms.
CannTrust said the rooms were eventually licensed in April.
It is unclear how much cannabis from the unlicensed rooms made its way to medical patients or the recreational market.
The producer said, “All product sold from the impacted rooms has passed quality control testing at Health Canada certified labs as well as CannTrust’s own quality control processes and safety reviews.”
Health Canada is conducting quality inspections on the confiscated samples from the Pelham greenhouse.
The company says the financial impact won’t be known until Health Canada completes its testing.
Results are expected in coming weeks, CannTrust said.
It is not known if the company faces any other possible penalties.
Health Canada and CannTrust did not immediately reply to queries from Marijuana Business Daily over the weekend.
该公司今天透露，总部位于安大略的特许大麻种植者 CannTrust 因向联邦监管机构提供未经许可的种植和不准确信息而受到加拿大卫生部的制裁。
CannTrust 位于安大略省佩勒姆的温室设施因经营五间无证客房而获得加拿大卫生部( Health Canada )的“违规”评级，并且至少有12500公斤（27500磅）被市场拒之门外。
2018财年， Agrima 植物药获得了不合格评级， Natural Med Company 获得了两个此类评级。这三起案件均发出警告信。
此外， CannTrust 表示，它对大约7500公斤的干大麻实行了“自愿持有”，相当于其 Vaughan 生产设施中生产的未经许可的地区。
去年10月至2019年3月，无证客房数量不断增加，而佳能信托( CannTrust )表示，在此期间，该公司有待审的客房申请。
该生产商表示，“所有从受影响房间销售的产品都通过了加拿大卫生部认证实验室的质量控制测试，以及 CannTrust 自己的质量控制流程和安全审查。”
加拿大卫生部正在对从 Pelham 温室没收的样本进行质量检查。
加拿大卫生部和 CannTrust 周末没有立即回复《大麻商业日报》的询问。